These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16628185)

  • 1. Chromosomal aberrations in leukaemia cells may delete tumour target antigens of stem cell-based immunotherapy.
    Hambach L; Nijmeijer BA; Drabbels JJ; Falkenburg JH; Goulmy E
    Leukemia; 2006 Jul; 20(7):1298-300. PubMed ID: 16628185
    [No Abstract]   [Full Text] [Related]  

  • 2. T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation.
    Schetelig J; Kiani A; Schmitz M; Ehninger G; Bornhäuser M
    Cancer Immunol Immunother; 2005 Nov; 54(11):1043-58. PubMed ID: 15887014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PRAME protein expressed in leukemia cells as a target molecule for immunotherapy].
    Ikeda H; Matsushita M; Kawakami H
    Rinsho Ketsueki; 1999 Jun; 40(6):484-6. PubMed ID: 10422284
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccines in leukemia.
    Lu S; Wieder E; Komanduri K; Ma Q; Molldrem JJ
    Adv Pharmacol; 2004; 51():255-70. PubMed ID: 15464913
    [No Abstract]   [Full Text] [Related]  

  • 5. Marrow grafting and immunotherapy in identical twins with hematologic malignancies.
    Fefer A; Buckner CD; Clift RA; Fass L; Glucksberg H; Mickelson EM; Neiman P; Storb R; Thomas ED
    Trans Assoc Am Physicians; 1973; 86():178-84. PubMed ID: 4596452
    [No Abstract]   [Full Text] [Related]  

  • 6. Dendritic cells, T-cells and their possible role in the treatment of leukaemia and lymphoma.
    Davison GM
    Transfus Apher Sci; 2010 Apr; 42(2):189-92. PubMed ID: 20122870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minor histocompatibility antigens as targets of cellular immunotherapy in leukaemia.
    Falkenburg JH; Willemze R
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):415-25. PubMed ID: 15498713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prerequisites and possibilities of immunotherapy in acute leukemias].
    Zintl F; Plenert W; Aurich G
    Z Gesamte Inn Med; 1976 Apr; 31(8):227-32. PubMed ID: 1085536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in allogeneic hematopoietic stem cell transplantation--not just a case for effector cells.
    Troeger A; Meisel R; Moritz T; Dilloo D
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S59-64. PubMed ID: 15812533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of antileukaemia CTL lines and clones for adoptive cell therapy in paediatric patients given allogeneic haematopoietic stem cell transplantation.
    Montagna D; Maccario R; Locatelli F
    Int J Immunogenet; 2008 Aug; 35(4-5):389-93. PubMed ID: 18976444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the use of donor-derived iNKT cells for adoptive immunotherapy to prevent leukemia recurrence in pediatric recipients of HLA haploidentical HSCT for hematological malignancies.
    Dellabona P; Casorati G; de Lalla C; Montagna D; Locatelli F
    Clin Immunol; 2011 Aug; 140(2):152-9. PubMed ID: 21185785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour immunity and immunotherapy.
    Mullins GM
    Ir J Med Sci; 1978 Sep; 147(9):291-300. PubMed ID: 359503
    [No Abstract]   [Full Text] [Related]  

  • 13. T-cell therapy after hematopoietic stem cell transplantation.
    Kennedy-Nasser AA; Brenner MK
    Curr Opin Hematol; 2007 Nov; 14(6):616-24. PubMed ID: 17898565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific cellular immunotherapy of leukemia.
    Van Driessche A; Gao L; Stauss HJ; Ponsaerts P; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    Leukemia; 2005 Nov; 19(11):1863-71. PubMed ID: 16121214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WT1-targeted immunotherapy of leukaemia.
    Xue S; Gao L; Gillmore R; Bendle G; Holler A; Downs AM; Tsallios A; Ramirez F; Ghani Y; Hart D; Alcock S; Tranter A; Stauss HJ; Morris E
    Blood Cells Mol Dis; 2004; 33(3):288-90. PubMed ID: 15528146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia.
    Anguille S; Van Tendeloo VF; Berneman ZN
    Leukemia; 2012 Oct; 26(10):2186-96. PubMed ID: 22652755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complex chromosome damages in patients with recurrent acute leukemias after allogeneic hematopoietic stem cell transplantations].
    Gindina TL; Mamaev NN; Barkhatov IM; Solomonova IS; Semenova EV; Zubarovskaia LS; Morozova EV; Rudnitskaia IuV; Popova MA; Alekseev SM
    Ter Arkh; 2012; 84(8):61-6. PubMed ID: 22994092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted cellular immunotherapy for leukemia patients.
    Casalegno-Garduño R; Schmitt A; Wang X; Xu X; Schmitt M
    Transfus Apher Sci; 2010 Oct; 43(2):207-10. PubMed ID: 20678962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia-associated antigens as target structures for a specific immunotherapy in chronic myeloid leukemia.
    Greiner J; Schmitt M
    Eur J Haematol; 2008 Jun; 80(6):461-8. PubMed ID: 18284627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of leukemia specific antigen and immunotherapy of acute leukemia with cell-wall skeleton of BCG.
    Ohno R; Ezaki K; Morishima Y; Kodera Y; Yamada K
    Nihon Ketsueki Gakkai Zasshi; 1978 Dec; 41(6):1134-41. PubMed ID: 87101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.